NCT05773274 2026-06-03Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT TrialNational Cancer Institute (NCI)Phase 2 Recruiting100 enrolled